Facebook Launches Preventive Health Tool
Tool created in partnership with American Cancer Society, American College of Cardiology, AHA, CDC
Diagnosis & Disease Information
Flu Shots Benefit Patients Hospitalized With Pneumonia
Study shows that in-hospital influenza vaccination may lower costs, risk for readmission or death
Xofluza Approved for Patients at High Risk of Flu-Related Complications
The FDA has approved a supplemental New Drug Application for Xofluza for the treatment of acute, uncomplicated influenza in patients aged 12 years and older at high risk of influenza-related complications who have been symptomatic for no more than 48 hours.
CDC: Seasonal Influenza Viruses Circulating in Southern Hemisphere
Influenza A(H3) predominating in many regions in Southern Hemisphere; influenza activity low in U.S.
CDC: Updated Influenza Vaccination Recommendations for 2019-2020
The Advisory Committee on Immunization Practices (ACIP) has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2019–2020 season. For the 2019–2020 season, the following influenza vaccines will be available: Trivalent influenza vaccines (A/Brisbane/02/2018 (H1N1)pdm09–like virus, A/Kansas/14/2017 (H3N2)–like virus, B/Colorado/06/2017–like virus [Victoria lineage]) Quadrivalent influenza vaccines (includes 3 viruses…
Pediatric Flu Vaccine Guidelines Updated for 2019-20 Season
Any form of licensed, age-appropriate vaccine is acceptable, with no preferred formulation or product
FDA Warns of “Cure-All” Products That Actually Contain Bleach
The FDA is warning consumers to stop using products known as Miracle or Master Mineral Solution, Miracle Mineral Supplement, MMS, Chlorine Dioxide Protocol, and Water Purification Solution due to numerous reports of significant health issues.
Flu Vaccine Tied to Better Long-Term Outcomes in Elderly ICU Survivors
Those who are vaccinated have lower risk for stroke, death in year following ICU discharge
Baloxavir Safe, Effective in Pediatric Influenza Study
According to results from the MINISTONE-2 trial, baloxavir marboxil (Xofluza) was found to be safe and effective in children 1 to less than 12 years old with an influenza infection.
2018-2019 Influenza Season in US Longest in 10 Years
Season was of moderate severity and lasted 21 weeks; illness mainly attributed to influenza A viruses
